Home
Cancer Vaccines... Advancing Immuno-oncology
16 September - 17 September 2015
Cancer Vaccines... Advancing Immuno-oncology

Cancer Vaccines helps to boost the immune system's recognition and resistance to cancer cells. Thus, increased knowledge of our immune system has opened up new combination therapies in immuno-oncology, to enhance immune response, as some the latest treatments incorporate monoclonal antibodies and genetically engineered viral vectors to kill tumours.

In addition, two- panel discussions on both days will bring some key questions to light including the commercial viability of personalised treatments.


 

Some of the hottest topics will include:
• CAR T-Cell Therapy
• Oncolytic viral therapies
• Gene-therapy
• Adoptive T-Cell transfer

However, it has also become clear that cancer cells have different ways of eluding the immune system, which makes creating effective vaccines difficult.

Researchers are also studying the best way to give vaccines, looking to see if they work better when used alone or with other types of cancer treatments. Therefore key discussion points in our 2-day interactive panel will include:

  • Development of combination treatments - which ones are best?
  • Driving the next generation tools in cancer immunotherapy
  • How will technology and data systems need to change in order to allow personalised treatment to evolve?

FEATURED SPEAKERS

Dr. Ravi Madan

Dr. Ravi Madan

, National Cancer Institute
Linda F. Powers

Linda F. Powers

Chair and CEO, Northwest Biotherapeutics
Michael G. Hanna, Jr.

Michael G. Hanna, Jr.

Founder & Chairman Emeritus, Vaccinogen, Inc.
Sebastian Kreiter

Sebastian Kreiter

VP Immunotherapy , BioNTech RNA Pharmaceuticals
Thomas Felzmann

Thomas Felzmann

CEO, Activartis Biotech GmbH
Vaios Karanikas

Vaios Karanikas

Biomarker Experimental Medicine Leader, Tumour Immunology, Roche Innovation Center Zurich

Aymen Al-Shamkhani

Professor in Immunology, University Of Southampton
Aymen Al-Shamkhani

Dr. Ravi Madan

, National Cancer Institute
Dr. Ravi Madan

Else Marie Agger

Director, Statens Serum Institut
Else Marie Agger

Eric Leire

CEO, DanDrit Biotech
Eric Leire

Farzin Farzaneh

Professor of Molecular Medicine, Kings College London
Farzin Farzaneh

Graham Pockley

Associate Director & Professor of Immunobiology , Nottingham Trent University
Graham Pockley

Hardev Pandha

Professor of Medical Oncology, Consultant Physician in Medical Oncology, University of Surrey
Hardev Pandha

John Maudsley

CEO, Cancer Vaccines Ltd
John Maudsley

Linda F. Powers

Chair and CEO, Northwest Biotherapeutics
Linda F. Powers

Matt Johnson

CTO, Avacta Life Sciences
Matt Johnson

Michael G. Hanna, Jr.

Founder & Chairman Emeritus, Vaccinogen, Inc.
Michael G. Hanna, Jr.

Miles Rackliff

UK Sales Manager, IntelliCyt
Miles Rackliff

Sebastian Kreiter

VP Immunotherapy , BioNTech RNA Pharmaceuticals
Sebastian Kreiter

Stephanie McArdle

Senior Research Scientist, The John van Geest Cancer Research Centre, Nottingham Trent University
Stephanie McArdle

Thomas Felzmann

CEO, Activartis Biotech GmbH
Thomas Felzmann

Vaios Karanikas

Biomarker Experimental Medicine Leader, Tumour Immunology, Roche Innovation Center Zurich
Vaios Karanikas

Werner Lubitz

CEO, BIRD-C GmbH & CoKEG
Werner Lubitz

sponsors

Conference agenda

clock

8:30

Morning Coffee & Registration

clock

9:00

Opening remarks

Graham Pockely

Graham Pockely, Associate Director & Professor of Immunobiology, John van Geest Cancer Research Centre, Nottingham Trent University

Gabriele Multhoff

Gabriele Multhoff, University Professor in Experimentelle Radioonkologie und Strahlenbiologie and Group Leader, Technische Universität München and Helmholz Zentrum München

Stefan Stangl

Stefan Stangl, Junior group leader experimental oncology and radiobiology, Universitat Munchen

clock

9:10

Circulating Hsp70 as a biomarker of disease in cancer

Graham Pockely

Graham Pockely, Associate Director & Professor of Immunobiology, John van Geest Cancer Research Centre, Nottingham Trent University

Gabriele Multhoff

Gabriele Multhoff, University Professor in Experimentelle Radioonkologie und Strahlenbiologie and Group Leader, Technische Universität München and Helmholz Zentrum München

Stefan Stangl

Stefan Stangl, Junior group leader experimental oncology and radiobiology, Universitat Munchen

clock

9:50

Membrane Hsp70 expression in cancer and its theranostic potential

Graham Pockely

Graham Pockely, Associate Director & Professor of Immunobiology, John van Geest Cancer Research Centre, Nottingham Trent University

Gabriele Multhoff

Gabriele Multhoff, University Professor in Experimentelle Radioonkologie und Strahlenbiologie and Group Leader, Technische Universität München and Helmholz Zentrum München

Stefan Stangl

Stefan Stangl, Junior group leader experimental oncology and radiobiology, Universitat Munchen

clock

10:30

Morning Coffee

clock

11:00

Imaging and targeting of membrane Hsp70 expressing tumours using a novel tumour-penetrating peptide (TPP)

Graham Pockely

Graham Pockely, Associate Director & Professor of Immunobiology, John van Geest Cancer Research Centre, Nottingham Trent University

Gabriele Multhoff

Gabriele Multhoff, University Professor in Experimentelle Radioonkologie und Strahlenbiologie and Group Leader, Technische Universität München and Helmholz Zentrum München

Stefan Stangl

Stefan Stangl, Junior group leader experimental oncology and radiobiology, Universitat Munchen

clock

12:20

Conclusions and close of workshop

clock

13:30

Registration and Coffee

Michael Hanna

Michael Hanna, Founder & Emeritus, Vaccinogen

clock

14:00

The impact in Antigen discovery for Cancer Vaccines

Michael Hanna

Michael Hanna, Founder & Emeritus, Vaccinogen

clock

15:00

Afternoon Tea

clock

15:30

Patient population selection for treatment.

Michael Hanna

Michael Hanna, Founder & Emeritus, Vaccinogen

clock

16:30

Potential for development of epitope based vaccines for treatment and prevention.

Michael Hanna

Michael Hanna, Founder & Emeritus, Vaccinogen

clock

17:00

Chairman’s Closing Remarks and Close of Day One

Michael Hanna

Michael Hanna, Founder & Emeritus, Vaccinogen

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Farzin Farzaneh

Farzin Farzaneh, Professor of Molecular Medicine, Kings College London

clock

9:10

OPENING ADDRESS: The Provocative Issue of Tumor Genetic Heterogeneity in Immunotherapy

Michael G. Hanna, Jr.

Michael G. Hanna, Jr. , Founder & Chairman Emeritus, Vaccinogen, Inc.

 

  • You cannot treat a Heterogeneous disease with a Homogeneous treatment.
  •  Immunotherapy should be aimed at preventing recurrence not treating established tumors
  •  Immune longevity in Autologous Vaccine Immunotherapy
  • clock

    9:50

    Sponsored session: An introduction to Assays for Immune-Modulators and Immunotherapy on the iQue® Screener

    Miles Rackliff

    Miles Rackliff, UK Sales Manager, IntelliCyt

    Matt Johnson

    Matt Johnson, CTO, Avacta Life Sciences

    clock

    10:30

    Morning Coffee

    clock

    11:00

    Translational Biomarkers and Diognostic Tools in Oncology

    Vaios Karanikas

    Vaios Karanikas, Biomarker Experimental Medicine Leader, Tumour Immunology, Roche Innovation Center Zurich

  •  Analysis and interpretation of biomarker data to suppport key decision making during early clinical development
  • Enabling strategies and their implimentation for early preclinical/ clinical studies
  • Validating the predictive utility of biomarker candidates
     
     
  • clock

    11:40

    Establishing a fully-personalised cancer treatment

    Dr. Ravi Madan

    Dr. Ravi Madan, , National Cancer Institute

     

    ·          Phase I/II clinical trials
    ·          Augmenting T Cell response
    ·          Vaccine and checkpoint blockade combinations
    clock

    12:20

    Networking Lunch

    clock

    13:30

    Sponsored Session: DCVax®: Novel Personalized Immune Therapies for Solid Tumors

    Linda F. Powers

    Linda F. Powers, Chair and CEO, Northwest Biotherapeutics

  • Ms. Powers will discuss NW Bio’s DCVax® platform technology, a personalized, dendritic cell based active immunotherapy for solid tumors.
  •  Unlike conventional cancer drugs and other immune therapies, which use one active agent to hit one target on the cancer, DCVax mobilizes many active agents of the immune system to hit many targets on the cancer.

     

  • clock

    14:10

    Industry Perspective: Combination therapies to advance immune-oncology vaccines and enhance patient outcomes

    Thomas Felzmann

    Thomas Felzmann, CEO, Activartis Biotech GmbH

     

    ·          Multi-modal cancer immunotherapy – combining vaccines & ICP inhibitors
    ·          Prognostic and Predictive Markers to Support Identification of Effective Immunotherapy Combinations
    ·          Case study
    clock

    14:50

    Afternoon Tea

    clock

    15:20

    Four into One does go: The use of integrated genomic, proteomic, immunological and bioinformatic platforms to identify novel immunological biomarkers of disease and predict outcomes of disease

    Graham Pockley

    Graham Pockley, Associate Director & Professor of Immunobiology , Nottingham Trent University

     

    ·       Tumour-mediated immunoregulation and immunological barriers to successful therapeutic outcomes
    ·       Immunomics: Integrating platforms for the discovery of new cancer biomarkers
    ·       Case Study: Immunomics in prostate and breast cancer
    clock

    16:00

    Oncolytic virotherapy: cancer immunotherapy as nature intended

    Hardev Pandha

    Hardev Pandha, Professor of Medical Oncology, Consultant Physician in Medical Oncology, University of Surrey

    clock

    16:40

    Who is afraid about Bacterial Ghosts

    Werner Lubitz

    Werner Lubitz, CEO, BIRD-C GmbH & CoKEG

  • Biological active delivery vehicles
  • Adjuvant particles
  • Cancer immunotherapy

     

  • clock

    17:20

    PANEL DISCUSSION: Where is the Future for Cancer Vaccines?

     

    ·          When should we use personalised and non-personalised care?
    ·          How can we develop further understanding in identifying novel pathways
    ·          How accessible would fully- personalised treatments become? 
    ·          How will technology and data systems need to change in order to allow personalised treatment to evolve?

    Farzin Farzaneh

    Farzin Farzaneh, Professor of Molecular Medicine, Kings College London

    Dr. Ravi Madan

    Dr. Ravi Madan, , National Cancer Institute

    Linda F. Powers

    Linda F. Powers, Chair and CEO, Northwest Biotherapeutics

    Sebastian Kreiter

    Sebastian Kreiter, VP Immunotherapy , BioNTech RNA Pharmaceuticals

    Werner Lubitz

    Werner Lubitz, CEO, BIRD-C GmbH & CoKEG

    clock

    18:00

    Chairman’s Closing Remarks and Close of Day One

    Werner Lubitz

    Werner Lubitz, CEO, BIRD-C GmbH & CoKEG

    clock

    18:10

    Drinks Reception Sponsored by Northwest Biotherapeutics

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Farzin Farzaneh

    Farzin Farzaneh, Professor of Molecular Medicine, Kings College London

    clock

    9:10

    Therapeutic Cancer Vaccines

    Farzin Farzaneh

    Farzin Farzaneh, Professor of Molecular Medicine, Kings College London

     

    ·          Tumour immunology and interactions between cancer and the immune system
    ·          Immune based sculpting of the tumour - selection of the most resistant cancer cells
    ·          Cancer mediated immune suppression – inhibition of surveillance and stimulation of immune check points
    ·          New therapeutic interventions: Active vaccination strategies, check point inhibition and targeted cytotolytic cells (CARs and TCR modified T cells)
    clock

    9:50

    RNA- vaccinology: From ware-houses to actively personalized cancer vaccines

    Sebastian Kreiter

    Sebastian Kreiter, VP Immunotherapy , BioNTech RNA Pharmaceuticals

     

     

    ·          Simulating tumour-specific antigen recognition
    ·          Epitope design enables a pipeline of Multi-Antigen DNA Tumor Vaccines
    ·          Neo-antigen–specific CD4+ T cells recognize mutated neo-antigens
    clock

    10:30

    Morning Coffee

    clock

    11:00

    Developments and clinical trials in allogeneic cell-based vaccines

    John Maudsley

    John Maudsley, CEO, Cancer Vaccines Ltd

     

    ·          Deriving allogeneic dendritic cellsfor future scalability and feasibility of cellular cancer vaccines
    ·          Practicalities of vaccine clinical trials
    ·          Cancer vaccine trial designs
    ·          Implementing targeting of known tumour antigens
    clock

    11:40

    Afternoon chair opening address: Case study: Dendritic cell vaccine development for colorectal cancer

    Eric Leire

    Eric Leire, CEO, DanDrit Biotech

    clock

    12:20

    Networking Lunch

    clock

    13:30

    Differentiation pathways of effector and memory CD8+ T cells

    Aymen Al-Shamkhani

    Aymen Al-Shamkhani, Professor in Immunology, University Of Southampton

     

     

    ·         The protective role of memory CD8+ T cell subsets
    ·         Signalling pathways that regulate effector and memory CD8+ T cell generation
    ·         Memory T cell subsets generated by vaccines and natural infection
    clock

    14:10

    Long-term maintenance of T cell memory by liposomes

    Else Marie Agger

    Else Marie Agger, Director, Statens Serum Institut

    clock

    14:50

    Round table discussion: Engineering materials to improve immune response

  • What are some of the biggest challenges that limit immune response in DNA Vaccinations?
  • Development of combination treatments - which ones are best?
  • Translating antigen experession - or lack of it
  • clock

    15:30

    Peptides or DNA vaccines? Could Immunobody® be the answer?

    Stephanie McArdle

    Stephanie McArdle, Senior Research Scientist, The John van Geest Cancer Research Centre, Nottingham Trent University

     

    ·          Long peptides vaccination require adjuvants but different peptide work best with different adjuvant
    ·          DNA vaccine do not always generate high avidity T-cells
    ·          Could Immunobody® be the Universal antigen delivery system? 
    clock

    16:10

    Afternoon Tea

    clock

    16:40

    PANEL DISCUSSION

     

    ·          Are we closer to achieving sustained antitumor immune response?
    ·          Driving next generation tools in cancer immunotherapy
    ·          What progresses in the Genome-wide mutation identification initiatives have helped personalised immunology?

    Farzin Farzaneh

    Farzin Farzaneh, Professor of Molecular Medicine, Kings College London

    Eric Leire

    Eric Leire, CEO, DanDrit Biotech

    Stephanie McArdle

    Stephanie McArdle, Senior Research Scientist, The John van Geest Cancer Research Centre, Nottingham Trent University

    John Maudsley

    John Maudsley, CEO, Cancer Vaccines Ltd

    clock

    17:20

    Chair's Closing Remarks

    Eric Leire

    Eric Leire, CEO, DanDrit Biotech


    Founder & Chairman Emeritus
    Vaccinogen, Inc.
    VP Immunotherapy
    BioNTech RNA Pharmaceuticals
    CEO
    Cancer Vaccines Ltd
    CEO
    DanDrit Biotech
    Professor in Immunology
    University Of Southampton
    Senior Research Scientist
    The John van Geest Cancer Research Centre, Nottingham Trent University
    Biomarker Experimental Medicine Leader, Tumour Immunology
    Roche Innovation Center Zurich
    National Cancer Institute
    Associate Director & Professor of Immunobiology
    Nottingham Trent University
    CEO
    Activartis Biotech GmbH
    Professor of Medical Oncology, Consultant Physician in Medical Oncology
    University of Surrey
    Professor of Molecular Medicine
    Kings College London
    Director
    Statens Serum Institut
    Chair and CEO
    Northwest Biotherapeutics
    CTO
    Avacta Life Sciences
    UK Sales Manager
    IntelliCyt
    CEO
    BIRD-C GmbH & CoKEG

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    Workshops

    Tumour Genomic Heterogeneity in Immunotherapies

    Tumour Genomic Heterogeneity in Immunotherapies

    Marriott Hotel Regents Park
    15 September 2015
    London, United Kingdom

    Is your name on the list?

    Download

    An Interview with Graham Pockley, Professor of Immunobiology

    Download

    An interview with Sebastian Kreiter, VP of Immunotherapy at BioNTech RNA Pharmaceuticals

    Download

    An interview with Activartis GmbH

    Download

    Sponsors and Exhibitors


    IntelliCyt

    Sponsors and Exhibitors
    http://www.intellicyt.com

    IntelliCyt develops enabling high throughput/high content tools to profile suspension cells and their components to gain deeper insight into normal and disease processes, informing drug discovery and development and the diagnosis of disease. IntelliCyt’s platform is used worldwide in all of the top pharmaceutical, biotechnology, and bioscience research organizations.

    Media Partners


    DNAvaccine.com

    Official Media Partner
    http://www.dnavaccine.com/

    The DNA Vaccine Web was launched in 1995 by Robert Whalen. This eventually became DNAvaccine.com and has always been a central resource to the fields of DNA vaccinology and non-viral gene transfer. DNAvaccine.com has helped to teach people about nucleic acid vaccines, find funding opportunities, define collaborative networks, launch new companies, and much more.


    International Society of Vaccines (ISV)

    Official Media Partner
    https://www.isv-online.org



    Cancer Biomarkers (CBM)

    Official Media Partner
    http://www.iospress.nl/journal/cancer-biomarkers/

    Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.


    Journal for ImmunoTherapy of Cancer

    Official Media Partner
    http://www.immunotherapyofcancer.org/

    Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.


    BMC Cancer

    Official Media Partner
    http://www.biomedcentral.com/bmccancer

    BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.


    Journal of Chemotherapy

    Official Media Partner
    http://www.maneyonline.com/loi/joc

    Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research. The Journal publishes original experimental and clinical research articles, reviews, brief communications and letters on all aspects of antimicrobial, anticancer and immunomodulating chemotherapy. Review articles by authoritative experts on new trends and developments in the relevant fields are also invited.


    New Medicine

    Official Media Partner
    http://www.nmok.net

    New Medicine's Oncology Knowledgebase is a dynamic, daily updated, fully relational, user-friendly, comprehensive resource in global drug development in oncology.

    Media Partners


    Samedan

    Supporters
    http://www.samedanltd.com/magazine/13.

    International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Antibodies Online

    Supporters
    http://www.antibodies-online.com

    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Drug Discovery World

    Supporters
    http://www.ddw-online.com

    For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


    Int. J. of Immunological Studies

    Supporters
    http://www.inderscience.com/ijis

    IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Farmavita

    Supporters
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here


    EBR

    Supporters
    http://www.samedanltd.com

    European BioPharmaceutical Review (EBR) provides a dedicated platform of communication and information for the biopharmaceutical market across Europe, North America and the rest of the world. Each quarterly issue, 10,500 copies of the magazine are distributed to our specially-targeted readership with articles on the hottest topics written by eminent commentators from the biotech scene. www.samedanltd.com


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    LabRoots

    Supporters
    http://www.labroots.com/

    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.


    The Pharma Letter

    Supporters
    http://www.thepharmaletter.com/

    The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Labhoo

    Supporters
    http://www.labhoo.com



    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Bioscreening

    Supporters
    http://www.bioscreening.com



    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    IOS Press

    Supporters
    http://www.iospress.nl

    IOS Press publishes about 120 new books and 100 international journals each year covering topics ranging from computer science and mathematics to medicine and the natural sciences. All titles in this catalogue are available online as well as in print. Many titles are covered in the most important abstracting databases, such as Thomson Reuters / ISI, MEDLINE and SciVerse Scopus. Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008. IOS Press journals are available through the highly-regarded MetaPress platform.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

    Marriott Regents Park

    128 King Henry's Road
    London NW3 3ST
    United Kingdom

    Marriott Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.